home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Webinar on Effective Control of Documents and Records in Accordance with 21 CFR, Part 820 Subpart D and Subpart M

 
  April 28, 2016  
     
 


Compliance Trainings, Online
2016-05-02


Description :

The effective control of documents and records becomes the cornerstone for all quality management systems. Failure to adequately control documents and records in accordance with quality, regulatory, and statutory requirements will result in the FDA issuing Form 483 observations during an agency inspection.

If your organization is struggling with understanding the salient requirements associated with the control of documents and records, this webinar is for you. This webinar will help your organization better understand the FDA’s expectations for the control of documents and records, while providing insight into tools needed for establishing an effective approach for document control and records control.

For establishments already having a compliant approach to document and records control, this webinar will help reinforce requirements necessary to remain in compliance with FDA requirements.

Areas Covered in the Session :

Reviewing and understanding the requirements associated with 21 CFR, Part 820, Subparts D & M

Similarities with ISO 13485 requirements

Understanding current industry practices

Establishing effective document and record oversight

Components for an effective document control system (review, approval, and changes

Establishing an effective approach to the control records

Defining record retention periods

Identifying Quality records (DHR, DMR, & QSR)

Who Will Benefit:

Research & Development Departments

QA/QC Departments

Regulatory Affairs Departments

Quality Management Teams

Documentation Departments

Combination Products Design Personnel

 

Production Teams

 
 
Organized by: Compliance Trainings
Invited Speakers: Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine.
 
Deadline for Abstracts: 2016-05-02
 
Registration:

For more information about this event please visit

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1911

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.